Roberto Mignone sold $14M of TEVA
director at TEVA PHARMACEUTICAL INDUSTRIES LTD. 367,600 shares at an average of $39.06, traded Sep 18, 2026, filed Sep 22, 2026.
Score components
- +15RoleDirector
- +25Trade size$14.4M at market
- +20Share of holdings soldSold 100% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-397959, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | SOpen-market sale Ordinary Sharesindirect: [see footnote] | -367,600 | $39.06 | $14M | 0 | 20 d ago |
Related signals
Other insiders at TEVA PHARMACEUTICAL INDUSTRIES LTD and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 32Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | Brian Savage Interim Chief Legal Officer | $285k 7,342 shares | -46% | |
| 40Moderate | TEVA PHARMACEUTICAL INDUSTRIES LTD | Richard Daniell Exec. VP, European Commercial | $1.1M 70,961 shares | -59% | |
| 40Moderate | TEVA PHARMACEUTICAL INDUSTRIES LTD | Richard Daniell Exec. VP, European Commercial | $2.2M 140,372 shares | -419% | |
| 5Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | Christine Fox EVP, Head of U.S. Commercial | $98k 6,181 shares | -10% | |
| 21Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | Richard D Francis President and CEO | $376k 23,773 shares | -8% | |
| 30Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | Eric A Hughes See "Remarks" | $367k 23,251 shares | -100% | |
| 40Moderate | TEVA PHARMACEUTICAL INDUSTRIES LTD | Richard Daniell Exec. VP, European Commercial | $999k 62,250 shares | -100% | |
| 28Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | Richard D Francis President and CEO | $503k 31,342 shares | -11% | |
| 31Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | Eric A Hughes See "Remarks" | $400k 24,900 shares | -100% | |
| 36Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | Eliyahu Sharon Kalif EVP, Chief Financial Officer | $903k 55,750 shares | -27% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.